Antiparkinson drug overuse.
D002746:Chlorpromazine / Q000009:adverse effects; D006778:Hospitals, Psychiatric; D006801:Humans; D008605:Mental Health Services; D010276:Parasympatholytics / Q000009:adverse effects*; D010546:Perphenazine / Q000009:adverse effects; D013881:Thioridazine / Q000009:adverse effects; D014268:Trifluoperazine / Q000009:adverse effects
D010276:Parasympatholytics; D014268:Trifluoperazine; D010546:Perphenazine; D013881:Thioridazine; D002746:Chlorpromazine